OXYGENIX

Pharmaceutical preparations for the treatment of neoplasms, infectious and parasitic diseases, diseases of the blood and blood-forming organs, disorders involving the immune and endocrine systems, mental and behavioral disorders, diseases of the nervous, circulatory, respiratory, musculoskeletal, genito-urinary and digestive systems, diseases of the eye, ear, skin and subcutaneous tissue, congenital malformations, deformations and chromosomal abnormalities; anesthetics, hemotropic agents, antiseptics, hemostatics, transfusion agents, oxygen-transporting fluids, namely, blood substitutes and oxygen therapeutics for administration to living human bodies for medical purposes; blood substitutes for human use, hemoglobin solution

Pharmaceutical research and development